资讯

The Pharma Letter41 分钟
NICE backs Fruzaqla for NHS use
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Fruzaqla ...
The Pharma Letter48 分钟
Novartis’ hopes dashed for GCA indication for blockbuster
Swiss pharma giant Novartis has announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx (secukinumab ...